Categories & Effectiveness

Cognition

Processing Speed

4/10

Moderate evidence of effectiveness

Energy

Wakefulness / Alertness (Stimulant)

10/10

Strong evidence of effectiveness

Fatigue Reduction

7/10

Strong evidence of effectiveness

Dosage & Side Effects

Recommended Dosage

For most healthy adults, daily caffeine intake up to 400 mg is generally considered safe. Undesirable effects like anxiety or jitteriness often appear above this level, while toxic symptoms may begin around 1 gram (1000 mg), though significant individual variation exists. Pregnant women should limit intake (ideally ≤200 mg/day, though ≤300 mg/day appears safe), and recommended limits for children and adolescents are lower (around 2.5-3 mg per kg of body weight per day).

Potential Side Effects

Common side effects, especially above 400mg or in sensitive individuals, include anxiety, nervousness, jitteriness, irritability, nausea, palpitations, and restlessness. Severe risks associated with very high doses (gram quantities) or overdose include dangerous heart arrhythmias, seizures, metabolic disturbances like hypokalemia, rhabdomyolysis (muscle breakdown), and in rare cases, lethality. Individuals with pre-existing heart conditions, anxiety disorders, or those taking certain medications (like CYP1A2 inhibitors/inducers) may be at higher risk for adverse effects.

Bioavailability & Half-Life

Caffeine is absorbed rapidly and almost completely (around 99%) from the gut, typically reaching peak levels in the blood within 30 to 120 minutes after consumption. It distributes widely throughout the body's water compartments, easily crossing into the brain, and has relatively low binding to proteins in the blood (10-35%). Metabolism occurs primarily in the liver via the CYP1A2 enzyme, breaking caffeine down into active metabolites like paraxanthine; the speed of this process varies significantly between people due to genetics and factors like smoking or medication use. The elimination half-life (the time it takes for half the caffeine to leave your system) averages 3 to 6 hours in healthy adults but can range from roughly 2.3 to 9.9 hours depending on individual metabolic factors.

Interactions & Stacks

Caution is advised when combining caffeine with alcohol or certain medications, particularly those affecting the CYP1A2 liver enzyme (like some antibiotics, antidepressants, and oral contraceptives), as this can alter caffeine metabolism and effects. Due to significant genetic variations affecting how individuals process and react to caffeine (e.g., CYP1A2, COMT, adenosine receptor genes), responses can vary widely, influencing both effectiveness and side effect risk. Energy drinks containing caffeine plus other ingredients may produce different physiological effects compared to caffeine alone.

Benefits by Use Case

Enhancing Alertness/Wakefulness

Boosts alertness and reduces sleepiness by blocking adenosine receptors. Effects typically last 3-6 hours but vary individually.

Reducing Fatigue

Effectively combats feelings of tiredness and fatigue, particularly during periods of sleep deprivation. Overuse can lead to tolerance and withdrawal fatigue.

Improving Processing Speed

May enhance reaction time and speed of information processing according to some studies. Effects can be inconsistent and may not apply to all cognitive tasks.

Improving Memory (Mixed Evidence)

Some studies suggest improved memory recall speed or explicit memory in adults/elderly, especially during suboptimal times. Other studies show no effect or even impairment, particularly in children or with spatial working memory in habitual users.

Mechanism of Action

Caffeine primarily exerts its effects by acting as a competitive antagonist at adenosine A1 and A2A receptors throughout the central nervous system, blocking the natural calming actions of adenosine at concentrations achieved through normal consumption. By blocking A1 receptors, caffeine prevents adenosine from decreasing neuronal firing and neurotransmitter release; blocking A2A receptors particularly impacts dopamine pathways, contributing to its stimulating effects and influence on arousal, cognition, and learning. At much higher, typically toxic concentrations, caffeine can also inhibit phosphodiesterase enzymes, mobilize intracellular calcium by acting on ryanodine receptors, and block GABA-A receptors, potentially contributing to adverse effects seen in overdose situations like seizures and arrhythmias.

Frequently Asked Questions

Is caffeine addictive?

When should I take caffeine?

How much caffeine is too much?

Does caffeine improve memory?

Can caffeine cause anxiety?

Does caffeine tolerance build up?

Can I overdose on caffeine?

Summary & Expert Opinion

Caffeine is a widely used, effective stimulant for enhancing alertness and reducing fatigue, generally safe for most healthy adults up to 400mg/day. While its benefits for energy and wakefulness are well-supported, its effects on cognitive functions like memory and attention are less consistent and highly dependent on the individual, dose, and specific task. Significant variability exists in how people metabolize and respond to caffeine due to genetics and lifestyle factors. Healthy adults seeking temporary boosts in energy or alertness who tolerate it well may find caffeine beneficial, but children, adolescents, pregnant women, and individuals with anxiety, insomnia, certain heart conditions, or caffeine sensitivity should exercise caution or avoid it.

Research Studies

Showing 5 of 13 studies

Acute Caffeine Administration Impaired Spatial Working Memory in Habitual Coffee/Tea Drinkers: A Preliminary Randomized, Double-Blind Study (2024)

cognitive performance spatial working memory verbal working memory +1 more

Authors:

F M Kassim

Findings:

Acute caffeine administration significantly impaired spatial working memory (SWM) in a delay-independent manner among habitual caffeine consumers. No significant effects were observed on verbal working memory (VWM). These findings contradict the common belief that caffeine enhances cognitive performance.

Participants:

18 healthy participants, habitual coffee/tea drinkers

Dosage:

Single acute dose of 200 mg, PO (orally)

Study Quality Assessment:

Randomized, double-blind, placebo-controlled study involving 18 healthy participants. Methods included backward digit span and spatial span tasks under delay-dependent conditions. Described as a 'Preliminary' study. Data derived from a previous published study.

All Effects:

cognitive performance spatial working memory verbal working memory working memory

Brain activity during a working memory task after daily caffeine intake and caffeine withdrawal: a randomized double-blind placebo-controlled trial (2023)

Authors:

Carolin Franziska Reichert, Christian Cajochen, Francesco Santini, Hans-Peter Landolt, Helen Slawik, Janine Weibel, Stefan Borgwardt, Yu-Shiuan Lin

Dosage:

daily caffeine intake (amount not specified)

Study Quality Assessment:

randomized double-blind placebo-controlled trial

International society of sports nutrition position stand: caffeine and exercise performance (2021)

The Impact of Caffeine and Coffee on Human Health (2019)

The clinical toxicology of caffeine: A review and case study (2018)

cardiovascular effects lethality overdose +2 more

Authors:

Cyril Willson

Findings:

This review covers caffeine's history, clinical toxicology (features, pharmacokinetics, toxicokinetics, mechanisms, management), and presents a case reconstruction. It emphasizes dose-dependent effects, significant inter-individual variability, and the potential for toxicity and lethality at high doses (gram quantities), while noting rare cases of severe outcomes at lower doses in susceptible individuals. The case reconstruction of a 16-year-old male's death after consuming an estimated 327-524mg of caffeine explores potential pharmacokinetic (e.g., CYP1A2 metabolism) and pharmacodynamic factors (e.g., genetic variations in receptors/enzymes, underlying conditions) as explanations for the fatality at a seemingly low dose, concluding the exact cause remains unknown without more data.

Participants:

Review synthesizes data from human studies (healthy adults, specific demographics like age/sex/pregnancy status, individuals with pre-existing conditions, anorectic woman). Includes a case reconstruction of a 16-year-old male.

Dosage:

Generally safe daily intake for healthy adults stated as ≤400mg. Recommended limits mentioned: ≤2.5mg/kg (Health Canada) or ≤3mg/kg (EFSA) per day for children/adolescents; ≤300mg/day (appears safe) or ≤200mg/day (prudent) for pregnant women. Dose-dependent effects described: positive effects noted at 250mg, undesirable effects above 400mg (e.g., 500mg dose detailed), high sub-lethal dose symptoms at ~7-10mg/kg. Toxic symptoms reported to begin around 1g, hospitalization required at 2g, lethality possible at ≥3g (typically ≥5g, often 10-50g ingested in fatalities). Case reconstruction estimated intake: 327-524mg (3.60-5.75mg/kg). Chronic toxicity ('caffeinism') mentioned at 1-1.5g/day. Various doses cited from pharmacokinetic studies (Table 1: 100mg, 200mg, 250mg, 400mg, 500mg, 2mg/kg, 4mg/kg, 5mg/kg) and case reports (e.g., 560-800mg, ~565mg or 14mg/kg).

Study Quality Assessment:

The document is described as a review article including a case study/reconstruction, citing numerous references. It discusses methodologies like pharmacokinetics, toxicokinetics, mechanism of action analysis, and case reconstruction. Specific study types cited within the review include case-control studies and Monte Carlo simulations. The text acknowledges limitations such as substantial inter-individual variation in caffeine response, poor correlation between serum concentrations and clinical effects, potential confounding factors (e.g., co-ingested drugs, pre-existing conditions), and lack of specific data (e.g., genetic, histologic) in the presented case reconstruction. Author conflict of interest is disclosed (consultant to companies manufacturing caffeine products), alongside a statement that these companies had no influence or funding for this specific work. The research did not receive specific grant funding.

All Effects:

cardiovascular effects lethality overdose pharmacokinetics toxicology

The Safety of Ingested Caffeine: A Comprehensive Review (2017)

cardiovascular effects cognitive effects reproductive effects +2 more

Authors:

Christophe Bernard, Jennifer L Temple

Findings:

This comprehensive review concludes caffeine is relatively safe for healthy adults (up to 400mg/day), but poses risks for vulnerable groups like pregnant women (recommended <200-300mg/day due to links with miscarriage/low birth weight), children/adolescents (lower safe thresholds, concerns about energy drinks), and potentially those with mental illness or heart conditions. Caffeine affects cardiovascular function (dose-dependent BP/HR changes), sleep, cognition (complex effects, withdrawal reversal noted), and can interact with alcohol and medications; withdrawal syndrome is recognized.

Participants:

Humans across the lifespan (neonates, infants, children, adolescents, adults, elderly), including healthy individuals and vulnerable populations (pregnant/lactating women, individuals with heart conditions or mental illness). Specific groups mentioned include men, women, college students, African-American and Caucasian children. Animal studies (mice, rats) also cited.

Dosage:

General safe intake for healthy adults suggested up to 400mg/day. Lower limits recommended for vulnerable groups: <200mg/day (ACOG) or <300mg/day (EC/Health Canada) for pregnant women; 100mg/day (adolescents) and 2.5mg/kg/day (children) suggested thresholds (Nawrot et al., 2003; Seifert et al., 2011). Doses >200mg/day linked to reproductive risks (miscarriage, low birth weight). Caffeine intoxication criteria mention >250mg. Specific product doses cited (e.g., soda ~45mg, coffee ~100mg/cup, energy drinks 77-80mg up to >500mg, medications 30-200mg).

Study Quality Assessment:

Comprehensive review evaluating clinical trials, observational studies, systematic reviews, meta-analyses, and expert reviews. Mentions specific methodologies (e.g., dose-response, placebo-controlled, NHANES data, serum caffeine measurement, self-report, food diaries) and limitations (e.g., reliance on self-report, recall bias, confounding variables, lack of RCTs in some areas, heterogeneity in study designs/doses, lack of data on pre-existing conditions in some reports). Cites recommendations from health authorities (e.g., FDA, IOM, AAP, EFSA, Health Canada, ACOG, IARC). Authors' funding sources disclosed (NIH, ANR).

All Effects:

cardiovascular effects cognitive effects reproductive effects safety vulnerable populations

A systematic review and meta-analysis of prospective cohort studies (2016)

Food Components to Enhance Performance: An Evaluation of Potential Performance-Enhancing Food Components for Operational Rations (1994)

A Randomized Controlled Trial (RCT) on the Effect of Caffeine on Working Memory and Sustained Attention of Bachelor of. Medicine and Bachelor...

sustained attention working memory

Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine

dopaminergic neurotransmission gene expression neuronal firing +1 more

Findings:

Adenosine decreases neuronal firing and neurotransmitter release via A1 receptors. Via A2a receptors, adenosine, and consequently caffeine, can influence dopaminergic neurotransmission. Caffeine can also induce rapid changes in gene expression.

All Effects:

dopaminergic neurotransmission gene expression neuronal firing neurotransmitter release

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects

attention cognitive function memory +2 more

Findings:

This literature review found mixed results regarding caffeine's effects on cognitive function. Current research suggests caffeine may affect mood (potentially increasing anxiety, vigor, alertness, jitteriness; decreasing tiredness, sadness), enhances processing speed, but does not significantly affect attention. Most reviewed studies indicate positive effects on memory (short-term, long-term, working memory reaction time, information retrieval) in adults and the elderly, but potential negative effects on memory and processing speed were noted in children.

Participants:

Literature review summarizing studies involving humans (various age groups including children 9-10 yrs, young adults 18-40 yrs, adults 18-65 yrs, elderly 65-74 yrs; specific groups like medical students, e-sport players; sample sizes ranging from N=9 to N=434,900) and animals (rats).

Dosage:

Review covers studies using various caffeine sources and doses: specific single doses (65mg, 80mg, 130mg, 147.2mg, 149.5mg, 155mg, 180mg, 200mg) from coffee, energy drinks (Red Bull, 5 Hour Energy, Ai Reload), or capsules; chronic consumption levels (<1 cup to >3 cups per day); average daily intake in children (13.00 ± 43.73 mg/day). Dose-dependent effects on mood (vigor, anxiety) mentioned.

Study Quality Assessment:

Literature review summarizing multiple studies. Methodologies mentioned for summarized studies include: randomized controlled trials (RCT), double-blind, placebo-controlled, cross-over designs, cross-sectional, population-based using large biobanks (UK Biobank, ABCD study, ELSA-Brasil), specific assessment tools (POMS, STAI, VAS, CogTrack, Trail-making tests, N-Back Task, Eriksen Flanker Test, Go/No-go, Psychomotor Vigilance Test, Keep Track task), objective measures (salivary cortisol), statistical analyses (ANOVA, t-tests, regression). Acknowledges mixed results, need for larger sample sizes, and potential limitations (e.g., small sample size in one study [17]).

All Effects:

attention cognitive function memory mood processing speed

Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children

acute toxicity adverse effects behavioral effects +4 more

Findings:

This systematic review evaluated data from 380 studies (published 2001-2015) to determine if caffeine intake levels deemed safe by Health Canada in 2003 remain appropriate for healthy adults, pregnant women, adolescents, and children across five outcome areas (acute toxicity, cardiovascular, bone & calcium, behavior, development/reproduction). The review generally confirmed that intakes up to 400 mg/day for healthy adults, 300 mg/day for healthy pregnant women, and 2.5 mg/kg body weight/day for healthy children and adolescents are not associated with overt adverse health effects. While some effects were noted below these levels (e.g., physiological changes, effects in subgroups or under specific conditions like near bedtime), the overall weight of evidence supports these levels for healthy populations.

Participants:

Healthy adults, healthy pregnant women, healthy adolescents (aged 12–19 years), and healthy children (aged 3–<12 years).

Dosage:

Evaluated safety levels based on Health Canada (2003): up to 400 mg/day for healthy adults, 300 mg/day for healthy pregnant women, 2.5 mg/kg body weight/day for healthy children and adolescents. Acute toxicity comparator: 10 g/day.

Study Quality Assessment:

Systematic review conducted using IOM standards and guidance; protocol registered on PROSPERO (nos. CRD42015026704, CRD42015027413, CRD42015026673, CRD42015026609, CRD42015026736); searched PubMed, EMBASE, Cochrane Database (studies published June 2001-June 2015); screened >5000 articles, included 381 studies; used DistillerSR software; employed PECO framework; critically appraised individual studies using National Toxicology Program’s OHAT Risk of Bias Rating Tool; used a weight-of-evidence approach (based on IOM, NTP, GRADE) considering study quality, consistency, adversity level, magnitude of response; involved multidisciplinary scientific review team and scientific advisory board (SAB); data deposited in AHRQ SRDR. Strengths mentioned: transparency, rigor, large evidence base, multidisciplinary team. Weaknesses/Limitations acknowledged: complexity and heterogeneity of evidence, difficulty assessing chronic exposure for some endpoints, potential confounding, potential biases (pregnancy signal, recall bias), uncertainty in exposure characterization. Funding sources (ILSI North America, ABA, NCA) and potential conflicts of interest disclosed.

All Effects:

acute toxicity adverse effects behavioral effects bone health cardiovascular effects reproductive effects safety

The role of adenosine receptors in the central action of caffeine

adenosine receptor antagonism behavioral effects central nervous system +1 more

Findings:

Caffeine's behavioral effects are likely primarily due to its antagonism of A1 and A2a adenosine receptors in the central nervous system. Other potential biochemical mechanisms (calcium release, phosphodiesterase inhibition, GABA receptor blockade) are mentioned but implied to be less significant.

All Effects:

adenosine receptor antagonism behavioral effects central nervous system mechanism of action

We value your privacy

Categories & Effectiveness

Cognition

Processing Speed

Energy

Wakefulness / Alertness (Stimulant)

Fatigue Reduction

Dosage & Side Effects

Recommended Dosage

Potential Side Effects

Bioavailability & Half-Life

Interactions & Stacks

Benefits by Use Case

Enhancing Alertness/Wakefulness

Reducing Fatigue

Improving Processing Speed

Improving Memory (Mixed Evidence)

Mechanism of Action

Frequently Asked Questions

Summary & Expert Opinion

Research Studies

Acute Caffeine Administration Impaired Spatial Working Memory in Habitual Coffee/Tea Drinkers: A Preliminary Randomized, Double-Blind Study (2024)

Authors:

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

Brain activity during a working memory task after daily caffeine intake and caffeine withdrawal: a randomized double-blind placebo-controlled trial (2023)

Authors:

Dosage:

Study Quality Assessment:

International society of sports nutrition position stand: caffeine and exercise performance (2021)

Authors:

Study Quality Assessment:

The Impact of Caffeine and Coffee on Human Health (2019)

Authors:

The clinical toxicology of caffeine: A review and case study (2018)

Authors:

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

The Safety of Ingested Caffeine: A Comprehensive Review (2017)

Authors:

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

A systematic review and meta-analysis of prospective cohort studies (2016)

Study Quality Assessment:

Food Components to Enhance Performance: An Evaluation of Potential Performance-Enhancing Food Components for Operational Rations (1994)

Authors:

A Randomized Controlled Trial (RCT) on the Effect of Caffeine on Working Memory and Sustained Attention of Bachelor of. Medicine and Bachelor...

Participants:

Study Quality Assessment:

Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine

Findings:

All Effects:

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

The role of adenosine receptors in the central action of caffeine

Findings:

All Effects:

Similar Nootropics

Green Tea

L-Theanine

Bacopa Monnieri